JP2016532643A5 - - Google Patents

Download PDF

Info

Publication number
JP2016532643A5
JP2016532643A5 JP2016520591A JP2016520591A JP2016532643A5 JP 2016532643 A5 JP2016532643 A5 JP 2016532643A5 JP 2016520591 A JP2016520591 A JP 2016520591A JP 2016520591 A JP2016520591 A JP 2016520591A JP 2016532643 A5 JP2016532643 A5 JP 2016532643A5
Authority
JP
Japan
Prior art keywords
delivery device
transdermal delivery
acid
dexmedetomidine
subject
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2016520591A
Other languages
English (en)
Japanese (ja)
Other versions
JP2016532643A (ja
JP6231670B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2014/059058 external-priority patent/WO2015054063A1/en
Publication of JP2016532643A publication Critical patent/JP2016532643A/ja
Publication of JP2016532643A5 publication Critical patent/JP2016532643A5/ja
Application granted granted Critical
Publication of JP6231670B2 publication Critical patent/JP6231670B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2016520591A 2013-10-07 2014-10-03 非鎮静性デクスメデトミジン経皮組成物を用いる、離脱症候群の治療法及び組成物 Active JP6231670B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201361887871P 2013-10-07 2013-10-07
US61/887,871 2013-10-07
PCT/US2014/059058 WO2015054063A1 (en) 2013-10-07 2014-10-03 Methods and compositions for treating withdrawal syndromes using non-sedative dexmedetomidine transdermal compositions

Publications (3)

Publication Number Publication Date
JP2016532643A JP2016532643A (ja) 2016-10-20
JP2016532643A5 true JP2016532643A5 (cg-RX-API-DMAC7.html) 2017-09-28
JP6231670B2 JP6231670B2 (ja) 2017-11-15

Family

ID=52777130

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2016520591A Active JP6231670B2 (ja) 2013-10-07 2014-10-03 非鎮静性デクスメデトミジン経皮組成物を用いる、離脱症候群の治療法及び組成物

Country Status (11)

Country Link
US (1) US20150098983A1 (cg-RX-API-DMAC7.html)
EP (1) EP3054934B1 (cg-RX-API-DMAC7.html)
JP (1) JP6231670B2 (cg-RX-API-DMAC7.html)
KR (2) KR101881791B1 (cg-RX-API-DMAC7.html)
CN (1) CN105682650B (cg-RX-API-DMAC7.html)
CA (1) CA2924190C (cg-RX-API-DMAC7.html)
ES (1) ES2983565T3 (cg-RX-API-DMAC7.html)
FI (1) FI3054934T3 (cg-RX-API-DMAC7.html)
RU (1) RU2648817C2 (cg-RX-API-DMAC7.html)
TW (1) TWI624278B (cg-RX-API-DMAC7.html)
WO (1) WO2015054063A1 (cg-RX-API-DMAC7.html)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI709417B (zh) * 2013-10-07 2020-11-11 美商帝國製藥美國股份有限公司 使用右美托咪啶經皮組成物用於治療注意力不足過動症、焦慮及失眠的方法及組成物
GB201600918D0 (en) * 2016-01-18 2016-03-02 Buzzz Pharmaceuticals Ltd Transdermal patch
KR20190060007A (ko) * 2016-10-31 2019-05-31 테이코쿠 팔마 유에스에이, 인코포레이티드 덱스메데토미딘 경피 전달 장치를 이용한 통증을 관리하는 방법
IL267689B2 (en) 2016-12-31 2025-05-01 Bioxcel Therapeutics Inc Use of sublingual dexmedetomidine for the treatment of agitation
CN111447927A (zh) * 2017-12-08 2020-07-24 帝国制药美国公司 纳洛酮经皮给药装置及其使用方法
IL279713B2 (en) 2018-06-27 2025-01-01 Bioxcel Therapeutics Inc Dexmedetomidine-containing layer compositions and methods for their production
WO2020006119A1 (en) 2018-06-27 2020-01-02 Bioxcel Therapeutics, Inc. Methods for treating agitation using dexmedetomidine hydrochloride
CN112996491A (zh) * 2018-10-15 2021-06-18 阿姆农·瓦尔迪 缓释大麻素及其产品
MX2021004737A (es) * 2018-10-24 2021-06-04 Saniona As Composiciones de tropano transdermicas y metodos para usar las mismas.
CA3135552C (en) * 2019-04-17 2023-09-26 Lts Lohmann Therapie-Systeme Ag Ketamine containing transdermal therapeutic system comprising free hydroxyl groups
EP3999058A4 (en) 2019-07-19 2023-05-03 Bioxcel Therapeutics, Inc. TREATMENT SCHEMES FOR NON-SEDATING DEXMEDETOMIDIN
CN121401263A (zh) 2020-02-14 2026-01-27 帝国制药美国公司 外用纳洛酮组合物及其使用方法
JP2023545372A (ja) * 2020-10-08 2023-10-30 バイオエクセル セラピューティクス,インコーポレイテッド デクスメデトミジン塩酸塩を用いた双極性障害及び精神病の治療
WO2022147537A1 (en) * 2021-01-04 2022-07-07 Bioxcel Therapeutics, Inc. Dexmedetomidine treatment regimens
CN115227638B (zh) * 2022-07-19 2025-03-18 广州新济生物医药研究院有限公司 一种盐酸右美托咪定可溶性微针及其制备方法
US20240207285A1 (en) * 2022-12-20 2024-06-27 Melt Pharmaceuticals, Inc. Midazolam and ketamine for enhanced sedation
US11806334B1 (en) 2023-01-12 2023-11-07 Bioxcel Therapeutics, Inc. Non-sedating dexmedetomidine treatment regimens
EP4687897A2 (en) * 2023-04-04 2026-02-11 Board of Regents, The University of Texas System Combinations including methocinnamox

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5217718A (en) * 1989-08-18 1993-06-08 Cygnus Therapeutic Systems Method and device for administering dexmedetomidine transdermally
US5124157A (en) * 1989-08-18 1992-06-23 Cygnus Therapeutic Systems Method and device for administering dexmedetomidine transdermally
GB9111732D0 (en) * 1991-05-31 1991-07-24 Orion Yhtymae Oy The use of certain salts of medetomidine and its optically active enantiomers to regulate the rate of transdermal administration of the drugs
PL181582B1 (pl) * 1995-06-07 2001-08-31 Ortho Mcneil Pharm Inc Plaster na skóre do zapobiegania owulacji u kobiety oraz plaster na skóre do przeprowadzania hormonalnej terapii substytucyjnej PL PL PL PL PL PL PL PL
GB9521680D0 (en) * 1995-10-23 1996-01-03 Orion Yhtymo Oy New use of imidazole derivatives
US5891868A (en) * 1997-11-21 1999-04-06 Kaiser Foundation Health Plan, Inc. Methods for treating postmenopausal women using ultra-low doses of estrogen
ES2228125T3 (es) * 1998-10-02 2005-04-01 3M Innovative Properties Company Sistemas de suministro de farmacos originados en las mucosas.
US20030170195A1 (en) * 2000-01-10 2003-09-11 Noven Pharmaceuticals, Inc. Compositions and methods for drug delivery
EP1652508B1 (en) * 2003-07-31 2013-12-04 Hisamitsu Pharmaceutical Co., Inc. Adhesive patch
JP4148988B2 (ja) * 2006-09-11 2008-09-10 積水化学工業株式会社 貼付剤
JP5547065B2 (ja) * 2008-05-15 2014-07-09 久光製薬株式会社 パロノセトロンを含有する経皮吸収製剤
US20130072532A1 (en) * 2010-01-08 2013-03-21 Recro Pharma, Inc. Topical transdermal dexmedetomidine compositions and methods of use thereof
CA2815898C (en) * 2010-11-17 2018-12-18 Hexal Ag Transdermal therapeutic system comprising buprenorphine
WO2013072763A2 (en) * 2011-11-16 2013-05-23 Nometics Inc. Non-sensitizing transdermal clonidine patch
EP2787970B1 (en) * 2011-12-11 2018-04-11 Recro Pharma, Inc. Intranasal dexmedetomidine compositions and methods of use thereof
US8242158B1 (en) * 2012-01-04 2012-08-14 Hospira, Inc. Dexmedetomidine premix formulation
ES2663412T3 (es) * 2012-01-31 2018-04-12 Grünenthal GmbH Parche farmacéutico para la administración transdérmica de (1R,4R)-6'-fluor-N,N-dimetil-4-fenil-4',9'-dihidro-3'H-espiro[ciclohexano-1,1'-pirano[3,4-b]indol]-4-amina

Similar Documents

Publication Publication Date Title
JP2016532641A5 (cg-RX-API-DMAC7.html)
JP2016532644A5 (cg-RX-API-DMAC7.html)
JP2016532645A5 (cg-RX-API-DMAC7.html)
FI3054934T3 (fi) Menetelmät ja koostumukset vieroitusoireyhtymien hoitoon käyttäen ei-sedatiivisia transdermaalisia deksmedetomidiinikoostumuksia
JP6188934B2 (ja) デクスメデトミジン経皮組成物を含む疼痛管理用方法及び組成物
JP6188933B2 (ja) 非鎮静量のデクスメデトミジンの経皮送達用方法及び組成物
US11197852B2 (en) Continuous delivery of lenalidomide and other immunomodulatory agents
FI3360575T3 (fi) Ihon kautta annosteltavat farmaseuttiset koostumukset, jotka käsittävät vaikuttavia aineita
RU2017111271A (ru) Опипрамоловый пластырь
RU2015100531A (ru) Капсулы с растворимым эстрадиолом для интравагинального введения
EP3939661B1 (en) Patch
JPWO2019142940A1 (ja) 皮膚貼付用粘着シート
JPWO2015025718A1 (ja) 貼付剤
JP7045045B2 (ja) 外用剤
JP2016532642A5 (cg-RX-API-DMAC7.html)
WO2021157457A1 (ja) ブロナンセリン含有貼付剤、及びその製造方法
CN107484412B (zh) 含有罗匹尼罗的贴剂
JP5642790B2 (ja) 貼付剤及びその粘着力増強方法
JP5623102B2 (ja) セレギリン含有貼付製剤
JP2021506783A (ja) 経皮薬物送達の間にデポを作成するための方法
JP2023531918A5 (cg-RX-API-DMAC7.html)
JP7683987B2 (ja) ブロナンセリン含有貼付剤、及びその製造方法
RU2814569C2 (ru) Препарат для наружного применения
CN118317769A (zh) 贴剂
WO2023100740A1 (ja) 貼付剤